Breaking News
National Institute of Health and Care Excellence (NICE)
About National Institute of Health and Care Excellence (NICE)
NICE’s role is to improve outcomes for people using the NHS and other public health and social care services. We do this by:
– Producing evidence-based guidance and advice for health, public health and social care practitioners.
– Developing quality standards and performance metrics for those providing and commissioning health, public health and social care services.
– Providing a range of information services for commissioners, practitioners and managers across the spectrum of health and social care.
NICE Recommends Novartis’ Piqray ® (Alpelisib) as a Targeted Treatment for Thousands of Advanced Breast Cancer Patients
July 18 2022
Today Novartis Pharmaceuticals UK announces that the National Institute for Health and Care Excellence (NICE) […]
NICE Recommends Use of Hansa Biopharma's Idefirix® (Imlifidase) as Desensitization Treatment for Highly Sensitized Kidney Transplant Patients
June 16 2022
Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA), pioneer in enzyme technology for rare immunological conditions, today […]
Patients to Have Earlier Access to Cutting-edge Treatments on NHS
June 9 2022
NHS patients in England will have early access to potentially life-saving and cutting-edge treatments thanks […]
NHS Fast Tracks New ‘Gamechanging’ Drug for Lung Cancer
March 21 2022
A targeted new drug for a rare and aggressive form of lung cancer will be […]
Life-extending Injection for Blood Cancer Available on the NHS
March 16 2022
A life-extending injection for a fatal form of blood cancer will be available to around […]
Immunotherapy Approved for Some People with Oesophageal Cancer on NHS in England
October 21 2021
The National Institute for Health and Care Excellence (NICE) has recommended the use of the […]
New Collaboration Between NICE and AHSN will Help Embed Innovations into the Healthcare System for the Benefit of Patients
August 20 2021
NICE and the Academic Health Science Network (AHSN) have today (4 August) announced a two-year […]
New Drug Combo for Advanced Breast Cancer Approved for NHS in England
August 13 2021
The National Institute of Health and Care Excellence (NICE) has approved the use of a […]
First Treatment Approved in England for Advanced Bile Duct Cancer
July 22 2021
The drug pemigatinib (Pemazyre) will now be an option for people with a rare type of bile […]